title: Cardiac PDEs and crosstalk between cAMP and cGMP signalling pathways in the regulation of contractility.
abstract: Elucidation of cAMP and cGMP signalling in the heart remains a hot topic, and new regulatory mechanisms continue to appear. Studying the influence of phosphodiesterases on 5-HT4 receptor signalling in porcine atrium, a paper from this issue of the journal expands findings of a crosstalk between cardiac cGMP and cAMP signalling recently discovered in failing rat ventricle to a different species and cardiac region. The overall data suggest that cGMP, produced following stimulation of the NPR-B receptor for C-type natriuretic peptide (CNP), inhibits cAMP degradation by phosphodiesterase 3 and thereby enhances cAMP-mediated signalling from β-adrenoceptors and 5-HT4 receptors to inotropic effects. In porcine atrium, this effect can be seen both as an increase in inotropic effect and as a reduced fade of the inotropic effect with time. Thus, accumulating evidence brings together several active fields of research, including cardiac phosphodiesterases, compartmentation of cyclic nucleotide signalling and the field of natriuretic peptides. If present in human hearts, this effect of CNP may have clinical implications.
authors: Finn Olav
authors: FO
authors: Levy
mesh_terms: D000818:Animals; D009320:Atrial Natriuretic Factor / Q000502:physiology; D000242:Cyclic AMP / Q000502:physiology*; D006152:Cyclic GMP / Q000502:physiology*; D006321:Heart / Q000502:physiology*; D006801:Humans; D009200:Myocardial Contraction / Q000502:physiology*; D010727:Phosphoric Diester Hydrolases / Q000502:physiology*; D044422:Receptors, Serotonin, 5-HT4 / Q000502:physiology; D015398:Signal Transduction
chemical_list: D044422:Receptors, Serotonin, 5-HT4; D009320:Atrial Natriuretic Factor; D000242:Cyclic AMP; D010727:Phosphoric Diester Hydrolases; D006152:Cyclic GMP
references: Br J Pharmacol. 2006 Jan;147(2):128-30
references: 16331292
references: J Biol Chem. 1962 Apr;237:1244-50
references: 13875173
references: Pharmacol Ther. 2006 Sep;111(3):674-706
references: 16960982
references: J Biol Chem. 1958 Jun;232(2):1077-91
references: 13549488
references: Circ Res. 2004 Jul 9;95(1):67-75
references: 15178638
references: Science. 2010 Mar 26;327(5973):1653-7
references: 20185685
references: Lancet. 1999 Jan 2;353(9146):9-13
references: 10023943
references: Br J Pharmacol. 2006 Jan;147(2):158-63
references: 16331293
references: Br J Pharmacol. 1990 Aug;100(4):879-85
references: 2169944
references: Science. 2002 Mar 1;295(5560):1711-5
references: 11872839
references: J Physiol. 1997 Nov 15;505 ( Pt 1):217-27
references: 9409484
references: Br J Pharmacol. 2009 Feb;156(4):575-86
references: 19159405
references: Nat Cell Biol. 2000 Jan;2(1):25-9
references: 10620803
references: Naunyn Schmiedebergs Arch Pharmacol. 1992 Nov;346(5):482-5
references: 1335123
references: JAMA. 2013 Mar 27;309(12):1268-77
references: 23478662
references: Naunyn Schmiedebergs Arch Pharmacol. 2004 Sep;370(3):157-66
references: 15365689
references: N Engl J Med. 1998 Dec 17;339(25):1810-6
references: 9854116
references: Br J Pharmacol. 1999 May;127(1):65-74
references: 10369457
references: Lancet. 1990 Jul 7;336(8706):1-6
references: 1694945
references: Eur J Pharmacol. 1993 Jan 5;230(1):103-5
references: 8428599
references: Br Heart J. 1975 Oct;37(10):1022-36
references: 1191416
references: Naunyn Schmiedebergs Arch Pharmacol. 1992 Dec;346(6):629-36
references: 1484564
references: Br J Pharmacol. 2011 Jan;162(1):54-71
references: 21133887
references: Circ Res. 2003 Nov 14;93(10):896-906
references: 14615493
references: Peptides. 2005 Mar;26(3):517-24
references: 15652659
references: Naunyn Schmiedebergs Arch Pharmacol. 1992 Nov;346(5):486-9
references: 1470219
references: N Engl J Med. 1991 Nov 21;325(21):1468-75
references: 1944425
references: Naunyn Schmiedebergs Arch Pharmacol. 2006 Dec;374(3):249-53
references: 17106669
references: N Engl J Med. 1996 May 23;334(21):1349-55
references: 8614419
references: Br J Pharmacol. 2008 Dec;155(7):1005-14
references: 18846035
references: Heart Fail Rev. 2004 Jul;9(3):209-16
references: 15809819
references: J Biol Chem. 1977 Jun 10;252(11):3854-61
references: 16921
references: EMBO Rep. 2004 Dec;5(12):1176-80
references: 15550931
references: JAMA. 2005 Apr 20;293(15):1900-5
references: 15840865
references: Nature. 1974 Oct 11;251(5475):515-7
references: 4424407
references: Br J Pharmacol. 2009 Jan;156(1):62-83
references: 19133992
references: Br J Pharmacol. 2013 Jun;169(3):528-38
references: 23489141
references: Circulation. 1996 Jun 1;93(11):1963-9
references: 8640969
references: Naunyn Schmiedebergs Arch Pharmacol. 2013 Aug;386(8):671-84
references: 23549671
references: J Biol Chem. 2004 Sep 3;279(36):37215-8
references: 15231839
references: Am J Physiol Cell Physiol. 2005 Aug;289(2):C455-61
references: 15788489
references: Circ Res. 2006 Apr 28;98(8):1081-8
references: 16556871
references: Br J Pharmacol. 1998 Mar;123(6):1182-8
references: 9559903
references: Lancet. 1993 Dec 11;342(8885):1441-6
references: 7902479
references: Neuropharmacology. 2008 Nov;55(6):1066-71
references: 18675829
references: Br J Pharmacol. 2006 Jan;147(2):140-57
references: 16331294
references: Am J Physiol Heart Circ Physiol. 2002 Oct;283(4):H1471-80
references: 12234799
references: Circ Res. 2005 Aug 5;97(3):268-76
references: 16002744
references: Br J Pharmacol. 2008 Feb;153(4):710-20
references: 18084319
references: Cardiovasc Res. 2005 Mar 1;65(4):869-78
references: 15721867
references: Naunyn Schmiedebergs Arch Pharmacol. 2007 Apr;375(2):123-31
references: 17318500
references: Mol Pharmacol. 1965 Sep;1(2):168-77
references: 5835697
references: N Engl J Med. 2000 Jul 27;343(4):246-53
references: 10911006
references: Adv Cyclic Nucleotide Res. 1981;14:391-7
references: 6269390
references: Naunyn Schmiedebergs Arch Pharmacol. 1990 Nov;342(5):619-22
references: 2090956
references: PLoS One. 2012;7(9):e45489
references: 23029047
references: Cardiovasc Res. 2005 Jan 1;65(1):211-20
references: 15621049
references: Lancet. 1999 Jun 12;353(9169):2001-7
references: 10376614
references: Naunyn Schmiedebergs Arch Pharmacol. 2011 Dec;384(6):543-53
references: 21901315
references: Eur J Heart Fail. 2009 Aug;11(8):771-8
references: 19567409
references: Br J Pharmacol. 2009 Jan;156(2):237-49
references: 19154438
references: Circ Res. 2006 Nov 10;99(10):1084-91
references: 17038640
references: Br J Pharmacol. 2007 Jan;150(2):143-52
references: 17160012
references: Cardiovasc Res. 2010 Mar 1;85(4):763-72
references: 19900965
references: N Engl J Med. 2011 Jul 7;365(1):32-43
references: 21732835
references: Naunyn Schmiedebergs Arch Pharmacol. 2012 Jun;385(6):565-77
references: 22426996
references: Cardiovasc Res. 2008 Dec 1;80(3):407-15
references: 18703533